Bloomberg News

J&J to Explore Options for Its Ortho Clinical Diagnostics Unit

January 22, 2013

J&J to Explore Options for Its Ortho Clinical Diagnostics Unit

Johnson & Johnson will review options for its Ortho Clinical Diagnostics business, which may include selling off the unit. Photographer: Brent Lewin/Bloomberg

Johnson & Johnson (JNJ:US) will review options for its Ortho Clinical Diagnostics business, which may include selling off the unit.

“At this time it is not certain that any transaction will be consummated,” the New Brunswick, New Jersey-based company said in a statement today.

To contact the reporter on this story: Bruce Rule in London at brule1@bloomberg.net

To contact the editor responsible for this story: Bruce Rule at brule1@bloomberg.net


Hollywood Goes YouTube
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

Companies Mentioned

  • JNJ
    (Johnson & Johnson)
    • $103.73 USD
    • 0.78
    • 0.75%
Market data is delayed at least 15 minutes.
 
blog comments powered by Disqus